Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association.

Buse JB, Ginsberg HN, Bakris GL, Clark NG, Costa F, Eckel R, Fonseca V, Gerstein HC, Grundy S, Nesto RW, Pignone MP, Plutzky J, Porte D, Redberg R, Stitzel KF, Stone NJ; American Heart Association; American Diabetes Association.

Diabetes Care. 2007 Jan;30(1):162-72. Review.

PMID:
17192355
2.

[Critical analysis of the American Diabetes Association dietary recommendations for cardiovascular disease in diabetes mellitus].

Santos AL, Weiss T, Duarte CK, Azevedo MJ, Zelmanovitz T.

Arq Bras Endocrinol Metabol. 2009 Jul;53(5):657-66. Review. Portuguese.

3.

Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA Diabetes Trials: a position statement of the American Diabetes Association and a Scientific Statement of the American College of Cardiology Foundation and the American Heart Association.

Skyler JS, Bergenstal R, Bonow RO, Buse J, Deedwania P, Gale EA, Howard BV, Kirkman MS, Kosiborod M, Reaven P, Sherwin RS; American Diabetes Association; American College of Cardiology Foundation; American Heart Association.

J Am Coll Cardiol. 2009 Jan 20;53(3):298-304. doi: 10.1016/j.jacc.2008.10.008. Review. No abstract available.

4.

Lipoprotein management in patients with cardiometabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology Foundation.

Brunzell JD, Davidson M, Furberg CD, Goldberg RB, Howard BV, Stein JH, Witztum JL; American Diabetes Association; American College of Cardiology Foundation.

Diabetes Care. 2008 Apr;31(4):811-22. doi: 10.2337/dc08-9018. Review. No abstract available.

PMID:
18375431
5.

Primary prevention of cardiovascular disease in people with dysglycemia.

Bianchi C, Miccoli R, Penno G, Del Prato S.

Diabetes Care. 2008 Feb;31 Suppl 2:S208-14. doi: 10.2337/dc08-s256. Review.

PMID:
18227487
6.

Aspirin for primary prevention of cardiovascular events in people with diabetes.

Pignone M, Alberts MJ, Colwell JA, Cushman M, Inzucchi SE, Mukherjee D, Rosenson RS, Williams CD, Wilson PW, Kirkman MS; American Diabetes Association; American Heart Association; American College of Cardiology Foundation.

J Am Coll Cardiol. 2010 Jun 22;55(25):2878-86. doi: 10.1016/j.jacc.2010.04.003. Review. No abstract available.

7.

Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group.

Wilson W, Taubert KA, Gewitz M, Lockhart PB, Baddour LM, Levison M, Bolger A, Cabell CH, Takahashi M, Baltimore RS, Newburger JW, Strom BL, Tani LY, Gerber M, Bonow RO, Pallasch T, Shulman ST, Rowley AH, Burns JC, Ferrieri P, Gardner T, Goff D, Durack DT; American Heart Association.

J Am Dent Assoc. 2008 Jan;139 Suppl:3S-24S. Review. Erratum in: J Am Dent Assoc. 2008 Mar;139(3):253.

PMID:
18167394
8.

Preventing cancer, cardiovascular disease, and diabetes: a common agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association.

Eyre H, Kahn R, Robertson RM; American Cancer Society, the American Diabetes Association, and the American Heart Association.Collaborative Writing Committee.

Diabetes Care. 2004 Jul;27(7):1812-24. Review.

PMID:
15220271
9.

Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group.

Wilson W, Taubert KA, Gewitz M, Lockhart PB, Baddour LM, Levison M, Bolger A, Cabell CH, Takahashi M, Baltimore RS, Newburger JW, Strom BL, Tani LY, Gerber M, Bonow RO, Pallasch T, Shulman ST, Rowley AH, Burns JC, Ferrieri P, Gardner T, Goff D, Durack DT; American Heart Association Rheumatic Fever, Endocarditis and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young; Council on Clinical Cardiology; Council on Cardiovascular Surgery and Anesthesia; Quality of Care and Outcomes Research Interdisciplinary Working Group; American Dental Association.

J Am Dent Assoc. 2007 Jun;138(6):739-45, 747-60. Review.

PMID:
17545263
10.

[Should we treat all diabetic patients with aspirin in primary prevention?].

Righetti A, De Moerloose P, Philippe J.

Rev Med Suisse. 2005 Jun 1;1(22):1500-4. Review. French.

PMID:
16025889
11.

Antiplatelet therapy for primary prevention in diabetes.

Ambrosi P, Villani P, Bouvenot G.

Diabetes Metab. 2006 Sep;32 Spec No2:2S52-6. Review.

PMID:
17375409
12.

Role of statins for the primary prevention of cardiovascular disease in patients with type 2 diabetes mellitus.

Riche DM, McClendon KS.

Am J Health Syst Pharm. 2007 Aug 1;64(15):1603-10. Review.

PMID:
17646562
13.

Molecular mechanisms of diabetic cardiovascular disease.

Hupfeld CJ, Wong GA.

Prev Cardiol. 2002 Fall;5(4):183-7. Review.

14.

Nonnutritive sweeteners: current use and health perspectives: a scientific statement from the American Heart Association and the American Diabetes Association.

Gardner C, Wylie-Rosett J, Gidding SS, Steffen LM, Johnson RK, Reader D, Lichtenstein AH; American Heart Association Nutrition Committee of the Council on Nutrition, Physical Activity and Metabolism, Council on Arteriosclerosis, Thrombosis and Vascular Biology, Council on Cardiovascular Disease in the Young, and the American D.

Circulation. 2012 Jul 24;126(4):509-19. Epub 2012 Jul 9. Review. No abstract available.

15.

Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics.

Kavey RE, Allada V, Daniels SR, Hayman LL, McCrindle BW, Newburger JW, Parekh RS, Steinberger J; American Heart Association Expert Panel on Population and Prevention Science; American Heart Association Council on Cardiovascular Disease in the Young; American Heart Association Council on Epidemiology and Prevention; American Heart Association Council on Nutrition, Physical Activity and Metabolism; American Heart Association Council on High Blood Pressure Research; American Heart Association Council on Cardiovascular Nursing; American Heart Association Council on the Kidney in Heart Disease; Interdisciplinary Working Group on Quality of Care and Outcomes Research.

Circulation. 2006 Dec 12;114(24):2710-38. Epub 2006 Nov 27. Review.

16.

Primary prevention of cardiovascular events and type 2 diabetes: should we prioritize our interventions?

Sultan A, Thuan JF, Avignon A.

Diabetes Metab. 2006 Dec;32(6):559-67. Review.

PMID:
17296509
17.

Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association.

Fox CS, Golden SH, Anderson C, Bray GA, Burke LE, de Boer IH, Deedwania P, Eckel RH, Ershow AG, Fradkin J, Inzucchi SE, Kosiborod M, Nelson RG, Patel MJ, Pignone M, Quinn L, Schauer PR, Selvin E, Vafiadis DK; American Heart Association Diabetes Committee of the Council on Lifestyle and Cardiometabolic Health, Council on Clinical Cardiology, Council on Cardiovascular and Stroke Nursing, Council on Cardiovascular Surgery and Anesthesia, Council on Quality of Care and Outcomes Research, and the American Diabetes Association.

Circulation. 2015 Aug 25;132(8):691-718. doi: 10.1161/CIR.0000000000000230. Epub 2015 Aug 5. Review.

18.

Cardiovascular prevention in patients with diabetes and prediabetes.

Anselmino M, Gohlke H, Mellbin L, Rydén L.

Herz. 2008 Apr;33(3):170-7. doi: 10.1007/s00059-008-3105-5. Review.

PMID:
18568310
19.
20.

[Acetylsalicylic acid and diabetes mellitus].

Paiva S.

Acta Med Port. 2002 May-Jun;15(3):199-202. Review. Portuguese.

Supplemental Content

Support Center